Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Aug 15;100(4):821–828. doi: 10.1172/JCI119597

Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

P Holm 1, N Korsgaard 1, M Shalmi 1, H L Andersen 1, P Hougaard 1, S O Skouby 1, S Stender 1
PMCID: PMC508254  PMID: 9259581

Abstract

The purpose of this study was to investigate whether endothelium-derived nitric oxide (NO) is involved in the plasma lipid-independent antiatherogenic effect of estrogen and levormeloxifene, a partial estrogen receptor agonist. 85 rabbits were ovariectomized and balloon-injured in the middle thoracic aorta. The rabbits were fed a cholesterol-enriched diet supplemented with 17beta-estradiol, levormeloxifene, or placebo, either alone, or together with 160 microg/ml NG-nitro- -arginine methyl ester (-NAME), an NO synthase inhibitor, in their drinking water for 12 wk. Plasma cholesterol was maintained at 25-30 mmol/liter by individualized cholesterol feeding. In the undamaged aorta, the extent of atherosclerosis in the estrogen group was only one-third that in the placebo group. Simultaneous administration of -NAME, however, significantly reduced the antiatherogenic effect of estrogen (P < 0.01). There was no significant difference between the placebo group given -NAME and the group treated with placebo alone. At the previously endothelium-denuded site, estrogen had no effect on atherosclerosis development, whereas -NAME combined with estrogen significantly increased atherogenesis (P < 0.05). The effects of levormeloxifene were almost similar to those of estrogen. Active vascular concentrations of -NAME were demonstrated in an additional study, in which maximal aortic/coronary endothelium-dependent relaxation was significantly inhibited in rabbits given -NAME. Thus, in this study a considerable part of the plasma lipid-independent antiatherogenic effect of estrogen was mediated through its effect on endothelial NO in cholesterol-fed rabbits. The results for levormeloxifene suggest a common mechanism of action for estrogen and partial estrogen receptor agonists on atherogenesis.

Full Text

The Full Text of this article is available as a PDF (196.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams M. R., Kaplan J. R., Manuck S. B., Koritnik D. R., Parks J. S., Wolfe M. S., Clarkson T. B. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 1990 Nov-Dec;10(6):1051–1057. doi: 10.1161/01.atv.10.6.1051. [DOI] [PubMed] [Google Scholar]
  2. Barrett-Connor E., Bush T. L. Estrogen and coronary heart disease in women. JAMA. 1991 Apr 10;265(14):1861–1867. [PubMed] [Google Scholar]
  3. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992 Jul;90(1):278–281. doi: 10.1172/JCI115849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  5. Candipan R. C., Wang B. Y., Buitrago R., Tsao P. S., Cooke J. P. Regression or progression. Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol. 1996 Jan;16(1):44–50. doi: 10.1161/01.atv.16.1.44. [DOI] [PubMed] [Google Scholar]
  6. Cayatte A. J., Palacino J. J., Horten K., Cohen R. A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994 May;14(5):753–759. doi: 10.1161/01.atv.14.5.753. [DOI] [PubMed] [Google Scholar]
  7. Collins P., Rosano G. M., Sarrel P. M., Ulrich L., Adamopoulos S., Beale C. M., McNeill J. G., Poole-Wilson P. A. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 1995 Jul 1;92(1):24–30. doi: 10.1161/01.cir.92.1.24. [DOI] [PubMed] [Google Scholar]
  8. De Mey J. G., Brutsaert D. L. Mechanical properties of resting and active isolated coronary arteries. Circ Res. 1984 Jul;55(1):1–9. doi: 10.1161/01.res.55.1.1. [DOI] [PubMed] [Google Scholar]
  9. Fischer-Dzoga K., Wissler R. W., Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue culture cells induced by hyperlipemic serum. Exp Mol Pathol. 1983 Dec;39(3):355–363. doi: 10.1016/0014-4800(83)90064-3. [DOI] [PubMed] [Google Scholar]
  10. Frazier-Jessen M. R., Kovacs E. J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol. 1995 Feb 15;154(4):1838–1845. [PubMed] [Google Scholar]
  11. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats. Br J Pharmacol. 1990 Sep;101(1):10–12. doi: 10.1111/j.1476-5381.1990.tb12079.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garg U. C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989 May;83(5):1774–1777. doi: 10.1172/JCI114081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gilligan D. M., Quyyumi A. A., Cannon R. O., 3rd Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994 Jun;89(6):2545–2551. doi: 10.1161/01.cir.89.6.2545. [DOI] [PubMed] [Google Scholar]
  15. Gisclard V., Miller V. M., Vanhoutte P. M. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther. 1988 Jan;244(1):19–22. [PubMed] [Google Scholar]
  16. Haarbo J., Leth-Espensen P., Stender S., Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991 Apr;87(4):1274–1279. doi: 10.1172/JCI115129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haarbo J., Svendsen O. L., Christiansen C. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res. 1992 Jun;70(6):1198–1202. doi: 10.1161/01.res.70.6.1198. [DOI] [PubMed] [Google Scholar]
  18. Hayashi T., Fukuto J. M., Ignarro L. J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11259–11263. doi: 10.1073/pnas.89.23.11259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hayashi T., Yamada K., Esaki T., Kuzuya M., Satake S., Ishikawa T., Hidaka H., Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995 Sep 25;214(3):847–855. doi: 10.1006/bbrc.1995.2364. [DOI] [PubMed] [Google Scholar]
  20. Hishikawa K., Nakaki T., Marumo T., Suzuki H., Kato R., Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995 Mar 6;360(3):291–293. doi: 10.1016/0014-5793(95)00124-r. [DOI] [PubMed] [Google Scholar]
  21. Holm P., Andersen H. O., Nordestgaard B. G., Hansen B. F., Kjeldsen K., Stender S. Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas. Atherosclerosis. 1995 Jun;115(2):191–200. doi: 10.1016/0021-9150(94)05513-i. [DOI] [PubMed] [Google Scholar]
  22. Kushwaha R. S., Hazzard W. R. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 1981 Apr;30(4):359–366. doi: 10.1016/0026-0495(81)90116-5. [DOI] [PubMed] [Google Scholar]
  23. Martin W., Villani G. M., Jothianandan D., Furchgott R. F. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther. 1985 Mar;232(3):708–716. [PubMed] [Google Scholar]
  24. Marui N., Offermann M. K., Swerlick R., Kunsch C., Rosen C. A., Ahmad M., Alexander R. W., Medford R. M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993 Oct;92(4):1866–1874. doi: 10.1172/JCI116778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993 Dec 30;329(27):2002–2012. doi: 10.1056/NEJM199312303292706. [DOI] [PubMed] [Google Scholar]
  26. Moncada S., Rees D. D., Schulz R., Palmer R. M. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2166–2170. doi: 10.1073/pnas.88.6.2166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Naruse K., Shimizu K., Muramatsu M., Toki Y., Miyazaki Y., Okumura K., Hashimoto H., Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation. Arterioscler Thromb. 1994 May;14(5):746–752. doi: 10.1161/01.atv.14.5.746. [DOI] [PubMed] [Google Scholar]
  28. Peng H. B., Libby P., Liao J. K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 1995 Jun 9;270(23):14214–14219. doi: 10.1074/jbc.270.23.14214. [DOI] [PubMed] [Google Scholar]
  29. Radomski M. W., Palmer R. M., Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987 Sep;92(1):181–187. doi: 10.1111/j.1476-5381.1987.tb11310.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Reis S. E., Gloth S. T., Blumenthal R. S., Resar J. R., Zacur H. A., Gerstenblith G., Brinker J. A. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994 Jan;89(1):52–60. doi: 10.1161/01.cir.89.1.52. [DOI] [PubMed] [Google Scholar]
  31. Sack M. N., Rader D. J., Cannon R. O., 3rd Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994 Jan 29;343(8892):269–270. doi: 10.1016/s0140-6736(94)91117-7. [DOI] [PubMed] [Google Scholar]
  32. Stamler J., Mendelsohn M. E., Amarante P., Smick D., Andon N., Davies P. F., Cooke J. P., Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res. 1989 Sep;65(3):789–795. doi: 10.1161/01.res.65.3.789. [DOI] [PubMed] [Google Scholar]
  33. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. E., Rosner B., Speizer F. E., Hennekens C. H. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991 Sep 12;325(11):756–762. doi: 10.1056/NEJM199109123251102. [DOI] [PubMed] [Google Scholar]
  34. Sulistiyani, Adelman S. J., Chandrasekaran A., Jayo J., St Clair R. W. Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):837–846. doi: 10.1161/01.atv.15.7.837. [DOI] [PubMed] [Google Scholar]
  35. Sullivan J. M., Vander Zwaag R., Lemp G. F., Hughes J. P., Maddock V., Kroetz F. W., Ramanathan K. B., Mirvis D. M. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med. 1988 Mar;108(3):358–363. doi: 10.7326/0003-4819-108-3-358. [DOI] [PubMed] [Google Scholar]
  36. Tsao P. S., McEvoy L. M., Drexler H., Butcher E. C., Cooke J. P. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation. 1994 May;89(5):2176–2182. doi: 10.1161/01.cir.89.5.2176. [DOI] [PubMed] [Google Scholar]
  37. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med. 1991 Oct 24;325(17):1196–1204. doi: 10.1056/NEJM199110243251702. [DOI] [PubMed] [Google Scholar]
  38. Ward J. E., Angus J. A. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. J Cardiovasc Pharmacol. 1993 May;21(5):804–814. doi: 10.1097/00005344-199305000-00018. [DOI] [PubMed] [Google Scholar]
  39. Weiner C. P., Lizasoain I., Baylis S. A., Knowles R. G., Charles I. G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212–5216. doi: 10.1073/pnas.91.11.5212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Williams J. K., Adams M. R., Herrington D. M., Clarkson T. B. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol. 1992 Aug;20(2):452–457. doi: 10.1016/0735-1097(92)90116-5. [DOI] [PubMed] [Google Scholar]
  41. Williams J. K., Adams M. R., Klopfenstein H. S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990 May;81(5):1680–1687. doi: 10.1161/01.cir.81.5.1680. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES